{
  "pmcid": "12414445",
  "sha256": "634e388a8c67c919aee2fe4469baa1314b9a0155d2284934b3b9d368da9ea91c",
  "timestamp_utc": "2025-11-09T15:40:29.431227+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 7.170666666666669,
    "reading_ease": 57.78266666666667,
    "word_count": 357
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients who underwent elective F/BEVAR for the treatment of TAAAs and cAAAs (only juxtarenal aneurysms) from 2013 – 2022 in the Vascular Quality Initiative database were included."
      },
      "Intervention": {
        "score": 1,
        "evidence": "This study assessed outcomes following fenestrated and branched endovascular aortic repair (F/BEVAR) for thoraco-abdominal aortic aneurysms (TAAAs) and complex abdominal aortic aneurysms (cAAAs) based on aneurysm size (small, medium, and large)."
      },
      "Objective": {
        "score": 1,
        "evidence": "Objective:: This study assessed outcomes following fenestrated and branched endovascular aortic repair (F/BEVAR) for thoraco-abdominal aortic aneurysms (TAAAs) and complex abdominal aortic aneurysms (cAAAs) based on aneurysm size (small, medium, and large)."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "Survival was evaluated using Kaplan–Meier curves and Cox regression."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 3 804 patients underwent F/BEVAR (small, n = 519; medium, n = 2 685; large, n = 600)."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "After adjustment, patients with large aneurysms had increased 30 day mortality (odds ratio [OR] 3.3, 95% confidence interval [CI] 1.3 – 10.1), long term mortality (hazard ratio [HR] 2.4, 95% CI 1.6 – 3.7), and prolonged length of stay (OR 1.87, 95% CI 1.2 – 2.9) compared with those with small aneurysms."
      },
      "Harms": {
        "score": 1,
        "evidence": "Peri-operative mortality (small, 1.0%; medium, 2.3%; large, 4.0%; p = .004), any complication (small, 14.6%; medium, 20.0%; large, 19.3%; p = .018), stroke (small, 0.4%; medium, 0.9%; large, 2.3%; p = .003), and prolonged length of stay (small, 6.7%; medium, 13.3%; large, 17.5%; p < .001) differed statistically significantly by aneurysm size."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 10,
    "max_score": 25
  }
}